Caribou Biosciences, Inc. (CRBU)
2.36
+0.05
(+2.16%)
USD |
NASDAQ |
May 29, 16:00
2.355
0.00 (0.00%)
After-Hours: 20:00
Caribou Biosciences Total Assets (Quarterly) : 149.00M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 3.179B |
| Beam Therapeutics, Inc. | 1.481B |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Oncolytics Biotech, Inc. | 8.161M |
| Sangamo Therapeutics, Inc. | 59.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 46.98M |
| Shareholders Equity (Quarterly) | 102.02M |
| Debt to Equity Ratio | 0.2641 |
| Current Ratio | 6.221 |
| Net Debt Paydown Yield | -0.05% |